ArticleJCEM case reports2026
Eiken syndrome presenting as pseudohypoparathyroidism due to
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudohypoparathyroidism (PHP) is a rare disorder characterized by classic hypocalcemia despite normal or elevated parathyroid hormone (PTH). Pseudohypoparathyroidism is marked by tissue resistance to circulating PTH and is associated with the typical Albright hereditary osteodystrophy (AHO) phenotype, including developmental delay, obesity, short stature, round face, brachydactyly, and ectopic ossifications. Pseudohypoparathyroidism is classified into multiple types based on the extent of clinical features and hormonal resistance beyond the parathyroid glands. We present a 15-year-old boy with recurrent seizures, developmental delay, deafness, poor dentition, and skeletal dysplasia. He did not have the typical AHO phenotype, and investigations revealed severe hypocalcemia, hyperphosphatemia, and elevated PTH, supporting a diagnosis of PHP. Imaging showed bilateral basal ganglia calcification, brachydactyly, clinodactyly, ischiopubic hypoplasia, and skeletal changes beyond those typically observed in patients with typical PHP. Whole-exome sequencing revealed a homozygous missense variant in exon 9 of the PTH1 receptor (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.